CureVac recordsdata expanded patent lawsuit in opposition to Pfizer/BioNTech over mRNA expertise – ET HealthWorld

0
4
CureVac recordsdata expanded patent lawsuit in opposition to Pfizer/BioNTech over mRNA expertise – ET HealthWorld


New Delhi: CureVac NV mentioned on Friday it had filed an expanded patent infringement declare in opposition to Pfizer Inc and BioNTech over the usage of mRNA expertise and {that a} U.S. court docket had granted its request to switch the trial.

The corporate mentioned it filed a counterclaim alleging that Pfizer and its German accomplice BioNTech infringed on 9 of its patents, broader than its authentic declare of three patents.

In July 2022, CureVac had filed a patent lawsuit in opposition to BioNTech over the usage of mRNA expertise within the corporations’ COVID-19 vaccine.

The switch of the trial to the Japanese District of Virginia from the Federal District Court docket of Massachusetts is anticipated to speed up progress of the case and permit for a probable 2024 trial date, CureVac mentioned on Friday.

Pfizer and BioNTech didn’t instantly reply to requests for remark.

Pfizer and BioNTech in response had filed a grievance with the U.S. District Court docket in Massachusetts, looking for a judgment that they didn’t infringe U.S. patents held by CureVac.

The businesses have beforehand advised the court docket that their COVID vaccine Comirnaty doesn’t work in the identical method as CureVac’s patented expertise.

Pfizer and BioNTech are additionally going through patent infringement lawsuits from different corporations.

  • Printed On Might 19, 2023 at 06:40 PM IST

Be a part of the group of 2M+ trade professionals

Subscribe to our publication to get newest insights & evaluation.

Obtain ETHealthworld App

  • Get Realtime updates
  • Save your favorite articles


Scan to obtain App




Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here